Sintx Technologies (NASDAQ:SINT) Stock Gets Price Target Bump from Ascendiant Capital Markets

Posted by Stacy Sanders on Oct 1st, 2026

Sintx Technologies (NASDAQ:SINT – Get Free Report) had its target price increased by Ascendiant Capital Markets from $12.00 to $12.50 in a research report issued on Thursday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Ascendiant Capital Markets’ price target suggests a potential upside of 460.54% from the stock’s current price.

A number of other research firms have also commented on SINT. Maxim Group reaffirmed a “buy” rating and set a $6.00 price objective on shares of Sintx Technologies in a research note on Thursday, June 4th. Weiss Ratings restated a “sell (e+)” rating on shares of Sintx Technologies in a report on Friday, July 17th. Three analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $9.50.

Get Our Latest Stock Report on Sintx Technologies

Sintx Technologies Stock Up 9.9%

SINT stock opened at $2.23 on Thursday. Sintx Technologies has a 1 year low of $1.40 and a 1 year high of $4.64. The stock’s 50 day moving average price is $1.67 and its 200 day moving average price is $2.04.

Sintx Technologies (NASDAQ:SINT – Get Free Report) last announced its earnings results on Tuesday, August 11th. The company reported ($0.75) EPS for the quarter, missing analysts’ consensus estimates of ($0.73) by ($0.02). Sintx Technologies had a negative net margin of 848.20% and a negative return on equity of 354.44%. The company had revenue of $0.45 million for the quarter, compared to analyst estimates of $0.46 million. On average, research analysts expect that Sintx Technologies will post -1.67 earnings per share for the current fiscal year.

Sintx Technologies Company Profile

(Get Free Report)

SINTX Technologies, Inc is an advanced materials company that develops and manufactures silicon nitride-based ceramics. Its technology is designed to provide properties such as high strength, wear resistance, biocompatibility and antimicrobial performance, supporting applications in healthcare and other demanding industries.

The company’s medical activities have focused on ceramic components and implantable products for orthopedic and spinal procedures, including technologies used in spinal fusion and other reconstructive applications.